Sulindac NDC 71205-648

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-648Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0648Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-648-30	71205064830	30 TABLET in 1 BOTTLE (71205-648-30)Marketed from Mar 28, 2022
71205-648-60	71205064860	60 TABLET in 1 BOTTLE (71205-648-60)Marketed from Mar 28, 2022
71205-648-90	71205064890	90 TABLET in 1 BOTTLE (71205-648-90)Marketed from Mar 28, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulindac
Generic name (nonproprietary): sulindac
Active ingredients: Sulindac — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072711
Marketing start: Jan 25, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 71205-648_d94e8865-d151-4fb1-bacd-f4e43819e3c2SPL ID d94e8865-d151-4fb1-bacd-f4e43819e3c2SPL set ID d94e8865-d151-4fb1-bacd-f4e43819e3c2RxCUI 198239UNII 184SNS8VUH
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205064830 followed by a unit qualifier and the quantity

Package 71205-0648-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 1, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Sulindac is indicated for acute or long-term use in the relief of signs and symptoms of the following: 1. Osteoarthritis 2. Rheumatoid arthritis** 3. Ankylosing spondylitis 4. Acute painful shoulder (Acute subacromial bursitis/supraspinatus tendinitis) 5. Acute gouty arthritis **The safety and effectiveness of sulindac tablets USP have not been established in rheumatoid arthritis patients who are designated in the American Rh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072711

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072711
Product	Strength	Form · route	Labeler	Product NDC
Sulindac	Sulindac 200 mg/1	TabletOral	A-S Medication Solutions	50090-0529
Sulindac	Sulindac 200 mg/1	TabletOral	PuraCap Laboratories LLC dba Blu Pharmaceuticals	24658-771
Sulindac	Sulindac 200 mg/1	TabletOral	Epic Pharma, LLC	42806-011